BDMD

Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.

Wall Street analysts forecast BDMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BDMD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Baird Medical Investment Holdings Ltd revenue for the last quarter amounts to -1.02M USD, decreased -70.78 % YoY.

Baird Medical Investment Holdings Ltd. EPS for the last quarter amounts to -780762.00 USD, decreased -43.51 % YoY.

Baird Medical Investment Holdings Ltd (BDMD) has 143 emplpoyees as of January 10 2026.

Today BDMD has the market capitalization of 47.75M USD.